FRAS1 Antikörper (PE)
-
- Target Alle FRAS1 Antikörper anzeigen
- FRAS1 (Fraser Syndrome 1 (FRAS1))
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser FRAS1 Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human FRAS1
- Isotyp
- IgG
- Top Product
- Discover our top product FRAS1 Primärantikörper
-
-
- Applikationshinweise
- FCM(1:20-100)
- Kommentare
-
Exitation/Emission: 480,565nm/578nm
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at 4°C
- Haltbarkeit
- 12 months
-
- Target
- FRAS1 (Fraser Syndrome 1 (FRAS1))
- Andere Bezeichnung
- Fras1 (FRAS1 Produkte)
- Hintergrund
-
This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].
Subcellular location: Extracellular
Synonyms: Extracellular matrix protein FRAS1, Fras 1, Fras1, FRAS1_HUMAN, Fraser syndrome 1.
-